Hormones of Adipose Tissue and Gestational Diabetes

Main Article Content

O.S. Payenok
О.О. Korytko
R.I. Petruniak


Obesity and gestational diabetes are the risk factors for complications both in the mother and in the fetus. Adipose tissue hormones (leptin, adiponectin, resistin) are secreted by the human placenta and regulate the function of trophoblast. The review presents data from the literature on the role of adipocytokines in the development of gestational diabetes and preeclampsia in obese women. The article considers the criteria and algorithms for the diagnosis of gestational diabetes recommended by the World Health Organization and the International Association of Diabetes and Pregnancy Study Group.

Article Details

How to Cite
Payenok, O., Korytko О., and R. Petruniak. “Hormones of Adipose Tissue and Gestational Diabetes”. INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine), no. 7.55, Oct. 2013, pp. 60-66, doi:10.22141/2224-0721.7.55.2013.84680.
Literature Review


Guelinckx I. et al. Maternal obesity: pregnancy complications, gestational weight gain and nutrition // Obesity Reviews. — 2008. — Vol. 9. — P. 140-150.

Bodnar L.M. et al. The risk of preeclampsia rises with increasing prepregnancy body mass index // Annals of Epidemio-logy. — 2005. — Vol. 15(7). — P. 475-482.

Kristensen J. et al. Pre-pregnancy weight and the risk ot stillbirth and neonatal death // BJOG: An International Journal of Obstetrics and Gynaecology. — 2005. — Vol. 112(4). — P. 403-408.

Sirimi N., Goulis D.G. Obesity in pregnancy // Hormones. — 2010. — Vol. 9(4). — P. 299-306.

Challier J., Galtier M., Bintein T. et al. Placental leptin receptor isoforms in normal and pathological pregnancies // Placenta. — 2003. — Vol. 24. — P. 92-99.

Weiwei T., Haiyan T., Juan C. et al. Expressions of adiponectin receptors in placenta and their correlation with preeclampsia // Reprod. Sci. — 2009. — Vol. 16. — P. 676-684.

McDonald E.A., Wolfe M.W. The pro-inflammatory role of adiponectin at the maternal-fetal interface // Am. J. Reprod. Immunol. — 2011. — Vol. 66. — P. 128-136.

Ouchi N., Kobayashi H., Kihara S. et al. Adiponectin stimulates angiogenesis by promoting cross-talk between AMP-activated proteinkinase and Akt signaling in endothelial cells // J. Biol. Chem. — 2004. — Vol. 279. — P. 1304-1309.

Jarvenpaa J., Vuoristo J.T., Santaniemi M. et al. Adiponectin induced placental cell apoptosis could be mediated via the ADIPOR1-receptor in pre-eclampsia with IUGR // J. Perinat. Med. — 2009. — Vol. 37. — P. 257-262.

Amaluddin M.S., Weakley S.M., Yao Q., Chen C. Resistin: functional roles and therapeutic considerations for cardiovascular disease // Br. J. Pharmacol. — 2012. — Vol. 165(3). — P. 622-632.

Miehle K., Holger S., Fasshauer M. Leptin, Adiponectin and other Adipokines in Gestational Diabetes Mellitus and Pre-eclampsia // Clin. Endocrinol. — 2012. — Vol. 76(1). — P. 2-11.

Misra V.K., Trudeau S. The Influence of Overweight and Obesity on Longitudinal Trends in Maternal Serum Leptin Levels During Pregnancy // Obesity. — 2011. — Vol. 192. — P. 416-421.

Catalano P.M., Hoegh M., Minium J. et al. Adiponectin in human pregnancy: implications for regulation of glucose and lipid metabolism // Diabetologia. — 2006. — Vol. 49. — P. 1677-1685.

Kajantie E, Hytinantti T., Hovi P. et al. Cord plasma adiponectin: a 20-fold rise between 24 weeks gestation and term // Journal of Clinical Endocrinology and Metabolism. — 2004. — Vol. 89. — P. 4031-4036.

Chen J., Tan B., Karteris E. et al. Secretion of adiponectin by human placenta: differential modulation of adiponectin and its receptors by cytokines // Diabetologia. — 2006. — Vol. 49. — P. 1292-1302.

Nien J.K., Mazaki-Tovi S., Romero R. et al. Resistin: a hormone which induces insulin resis¬tance is increased in normal pregnancy // Journal of Perinatal Medicine. — 2007. — Vol. 35. — P. 513-521.

Mazaki-Tovi S., Romero R., Kusanovic J.P. et al. Maternal visfatin concentration in normal pregnancy. // Journal of Perinatal Medicine. — 2009. — Vol. 37. — P. 206-217.

Ognjanovic S., Tashima L.S., Bryant-Greenwood G.D. The effects of pre-B-cell colony-enhancing factor on the human fetal membranes by microarray analysis // American Journal of Obstetrics and Gynecology. — 2003. — Vol. 189. — P. 1187-1195.

Vaisbuch E., Mazaki-Tovi S., Kusanovic J.P. et al. Retinol binding protein 4: an adipokine associated with intra-amniotic infection/inflammation // The Journal of Maternal-Fetal and Neonatal Medicine. — 2010. — Vol. 23. — P. 111-119.

Ueland T., Dalsoren T., Voldner N. et al. Retinol-binding protein-4 is not strongly associated with insulin sensitivity in normal pregnancies. // European Journal of Endocrinology — 2008. — Vol. 159. — P. 49-54.

Inoue S., Takamoto N., Akahori Y. et al. Elevated level of serum retinol-binding protein 4 in pregnancy-induced hypertension // The Journal of Obstetrics and Gynaecology Research. — 2009. — Vol. 35. — P. 293-300.

Esakoff T.F., Cheng Y.W., Sparks T.N., Caughey A.B. The association between birthweight 4000 gm or greater and perinatal outcomes in patients with and without gestational diabetes mellitus // Am. J. Obstet. Gynecol. — 2009. — Vol. 672. — E1-E4.

Yogev Y., Catalano P.M. Pregnancy and Obesity // Obstet. Gynecol. Clin. N. Am. — 2009. — Vol. 36. — P. 285-300.

Qiu C., Williams M.A., Vadachkoria S. et al. Increased maternal plasma leptin in early pregnancy and risk of gestational diabetes mellitus // Obstetrics and Gynecology. — 2004. — Vol. 103. — P. 519-525.

D’Anna R., Baviera G., Cannata M.L. et al. Midtrimester amniotic fluid leptin and insulin levels and subsequent gestational diabetes // Gynecologic and Obstetric Investigation. — 2007. — Vol. 64. — P. 65-68.

McLachlan K.A., O’Neal D., Jenkins A. et al. Do adiponectin, TNF alpha, leptin and CRP relate to insulin resistance in pregnancy? Studies in women with and without gestational diabetes, during and after pregnancy // Diabetes/Metabolism Research and Reviews. — 2006. — Vol. 22. — P. 131-138.

Ouchi N., Parker J.L., Lugus J.J. et al. Adipokines in inflammation and metabolic disease // Nature Reviews Immunology. — 2011. — Vol. 11. — P. 85-97.

Alberti K.G., Zimmet P.Z. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation // Diabet Med. — 1998. — Vol. 15. — P. 539-553.

Metzger B.E., Gabbe S.G., Persson B. et al. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy // Diabetes Care. — 2010. — Vol. 33. — P. 676-682.

International Association of Diabetes and Pregnancy Study Groups Recommendations on the Diagnosis and Classification of Hyperglycemia in Pregnancy // Diabetes Care. — 2010. — Vol. 33(3). — P. 676-682.

Wendland E.M., Torloni M.R., Falavigna M. et al. Gestational Diabetes and Pregnancy Outcomes. A Systematic Review of the World Health Organization (WHO) and the International Association of Diabetes in Pregnancy Study Groups (IADPSG) Diagnostic Criteria. BMC Pregnancy Childbirth. — 2012. —


Samolis S., Papastefanou I., Panagopoulos P. et al. Relation between first trimester maternal serum leptin levels and body mass index in normotensive and pre-eclamptic pregnancies — role of leptin as a marker of pre-eclampsia: a prospective case-control study // Gynecological Endocrinology. — 2010. — Vol. 26. — P. 338-343.

Ning Y., Williams M.A., Muy-Rivera M. et al. Relationship of maternal plasma leptin and risk of pre-eclampsia: a prospective study // The Journal of Maternal-Fetal and Neonatal Medicine. — 2004. — Vol. 15. — P. 186-192.

Hauguel-De Mouzon S., Lepercq J., Catalano P. The known and unknown of leptin in pregnancy // American Journal of Obstetrics and Gynecology. — 2006. — Vol. 194. — P. 1537-1545.